HRES 803 · Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Referred to the House Committee on Energy and Commerce.
- Introduced
- Oct 10, 2025
- Latest action
- Oct 10, 2025
- Sponsor
- Rep. John W. Rose [R-TN-6]
- Policy area
- Health
- Cosponsors
- 11
Recent actions
- Oct 10, 2025 Referred to the House Committee on Energy and Commerce.
- Oct 10, 2025 Submitted in House
- Oct 10, 2025 Submitted in House
Votes
No recorded votes are available for this bill.